Joos Clinical Projects
ActiveJoos Clinical Projects has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €519k and a net result of €73k. Equity is growing by ~5.6% per year across the filed fiscal years. Its solvency ranks better than 89% of 60 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
85
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability85▲+1
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 15.46 against 9.85 in 2024; short-term debt: 5.4% and cash: 20.3% of total assets), and 5.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
94.6%
Return on assets
13.3%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 09-01-2026, 22 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
22 d early
2024
4 d early
2023
27 d early
2022
22 d early
2021
4 d early
2020
6 d early
2019
25 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close16-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€519k▼ 3.6%
2024 · €539k
2019: €313k
2020: €397k
2021: €464k
2022: €492k
2023: €516k
2024: €539k
2019 → 2025
Total assets
€549k▼ 6.6%
2024 · €588k
2019: €406k
2020: €468k
2021: €526k
2022: €539k
2023: €550k
2024: €588k
2019 → 2025
Net result
€73k▲ 2.1%
2024 · €71k
2019: €93k
2020: €85k
2021: €107k
2022: €28k
2023: €77k
2024: €71k
2019 → 2025
Working capital
€428k▼ 1.7%
2024 · €436k
2019: €254k
2020: €330k
2021: €394k
2022: €410k
2023: €407k
2024: €436k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€464k-€492k▲ 5.9%€516k▲ 5.0%€539k▲ 4.4%€519k▼ 3.6%
Operating result€154k-€39k▼ 74.8%€91k▲ 134%€98k▲ 7.7%€113k▲ 15.2%
Net result€107k-€28k▼ 73.4%€77k▲ 170%€71k▼ 6.7%€73k▲ 2.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 15% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €549k
Fixed assets
€91k▼ 11.3%
Current assets
€458k▼ 5.6%
Equity and liabilities €549k
Equity
€519k▼ 3.6%
Debt
€30k▼ 39.8%
The debt ratio falls from 8.4% to 5.4%. Equity and debt are lower.
Key figures and ratios
EBITDA
€124k▲
2024 · €109k
Cash flow
€84k▲
2024 · €83k
Solvency
94.6%▲
2024 · 91.6%
Current ratio
15.46▲
2024 · 9.85
Quick ratio
15.46▲
2024 · 9.85
Debt / equity
0.06▼
2024 · 0.09
ROE
14.0%▲
2024 · 13.3%
ROA
13.3%▲
2024 · 12.1%
Interest coverage
316.14▲
2024 · 144.34
Debt
€30k▼
2024 · €49k
Debt ≤ 1 year
€30k▼
2024 · €49k
Income taxes
€43k▲
2024 · €29k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€588k€549k▼
Fixed assets21/28€103k€91k▼
Tangible fixed assets22/27€103k€91k▼
Land and buildings22€79k€74k▼
Plant, machinery and equipment23€5k€3k▼
Furniture and vehicles24€19k€14k▼
Current assets29/58€485k€458k▼
Amounts receivable after more than one year29€300k€300k=
Other amounts receivable291€300k€300k=
Amounts receivable within one year40/41€42k€46k▲
Trade receivables40€42k€41k▼
Other amounts receivable41-€4k
Cash at bank and in hand54/58€143k€112k▼
Deferred charges and accrued income490/1€561€545▼
Equity and liabilities
Total equity and liabilities10/49€588k€549k▼
Equity10/15€539k€519k▼
Contributions10/11€6k€6k=
Reserves13€458k€439k▼
Distributable reserves133€458k€439k▼
Profit (loss) carried forward14€74k€74k=
Amounts payable17/49€49k€30k▼
Amounts payable within one year42/48€49k€30k▼
Current portion of amounts payable after more than one year42€4k-
Trade debts44€6k€587▼
Suppliers440/4€6k€587▼
Taxes, remuneration and social security45€34k€22k▼
Taxes450/3€34k€22k▼
Other amounts payable47/48€7k€7k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€11k▼
Other operating charges640/8€743€1k▲
Non-recurring operating charges66A-€534
Gross operating margin9900€110k€125k▲
Operating profit (loss)9901€98k€113k▲
Financial income75/76B€4k€4k▼
Recurring financial income75€4k€4k▼
Financial charges65/66B€758€391▼
Recurring financial charges65€758€391▼
Profit (loss) for the period before taxes9903€101k€116k▲
Income taxes67/77€29k€43k▲
Profit (loss) for the period9904€71k€73k▲
Profit (loss) for the period to be appropriated9905€71k€73k▲
Appropriation of the result
Profit (loss) to be appropriated9906€145k€147k▲
Profit (loss) brought forward from the previous period14P€74k€74k=
Transfer from equity791/2€49k€92k▲
Transfer to equity691/2€71k€73k▲
To other reserves6921€71k€73k▲
Profit to be distributed694/7€49k€92k▲
Return on contributions (dividend)694€49k€92k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
27-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
04-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Equity above €500kEq €516k ▲5%
5 profitable years in a row build equity to €516k.
09-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial
Weakest financial yearnet €28k ▼73.4%
Net result drops to €28k, the lowest in the series; recovery starts the following year.
27-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial
Highest result since 2019net €107k ▲25.2%
Operating result €154k, net result €107k, both a record.
25-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
06-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
25-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
09-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
25-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Destelbergen · 1 establishment unit since 2009
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Broekstraat(HEU) 169070 DestelbergenGround area
1,049 m²
Building footprint
130 m²
Volume, LiDAR
775 m³
Parcel 44028B0238/00D000, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
JCP
since 20092.183.555.617
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44028B0238/00D000 | Flanders | 1,049 m² | 1 · 130 m² | 9.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GROUPE TETE PHARMACEUTICAL
BE 0542.600.182
Nivelles · Eq €518k
Pharma Chemicals France
BE 0741.620.032
Braine-le-Château · Eq €509k
MY®HEALTH
BE 0682.509.420
Lummen · Eq €487k
PHARMACIE DE GIVRY
BE 0897.812.697
Quévy · Eq €484k
MERIDIAN BIOSCIENCE EUROPE
BE 0408.081.968
Braine-l'Alleud · Eq €455k
Of 149 companies in sector 21100 we hold annual accounts for 108. 75 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-12-2009
Fiscal year end30-06
Abbreviation NL
JCP
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
64200Holdings
64210Activities of holding companies
70200Business and other management consultancy
70210Activities of head offices; management consultancy activities
70220Business consulting
73200Market research and public opinion polling
73300Public relations and communication consultancy
82100Office administrative and support services
82110Office administrative, office support and other business support activities
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:joos.evelyne@gmail.com
Phone:0477/780202